Caxton Associates LLP Merck & Co., Inc. Transaction History
Caxton Associates LLP
- $4.11 Billion
- Q3 2025
A detailed history of Caxton Associates LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 60,945 shares of MRK stock, worth $5.66 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
60,945
Previous 39,421
54.6%
Holding current value
$5.66 Million
Previous $3.12 Billion
99.84%
% of portfolio
0.12%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,878Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...